WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | United Therapeutics Corporation UTHR | WELLINGTON MANAGEMENT GROUP LLP | 2,463,891 5.500% | -1,330,119 (-35.06%) | Filing |
| 2024-02-08 10:18 am Sale | 2023-12-29 | 13G | United Therapeutics Corporation UTHR | WELLINGTON MANAGEMENT GROUP LLP | 3,794,010 8.070% | -894,814 (-19.08%) | Filing |
| 2023-07-10 08:44 am Purchase | 2023-06-30 | 13G | United Therapeutics Corporation UTHR | WELLINGTON MANAGEMENT GROUP LLP | 4,688,824 10.010% | 2,119,561 (+82.50%) | Filing |
| 2023-02-06 2:58 pm Purchase | 2022-12-30 | 13G | United Therapeutics Corporation UTHR | WELLINGTON MANAGEMENT GROUP LLP | 2,569,263 5.640% | 2,569,263 (New Position) | Filing |